SPY366.69-0.10 -0.03%
DIA300.06+0.88 0.29%
IXIC12,377.18+27.82 0.23%

Monopar Therapeutics Q3 EPS $(0.15) Down From $(0.08) YoY

Monopar Therapeutics (NASDAQ:MNPR) reported quarterly losses of $(0.15) per share. This is a 87.5 percent decrease over losses of $(0.08) per share from the same period last year.

· 11/12/2020 09:20
Monopar Therapeutics (NASDAQ:MNPR) reported quarterly losses of $(0.15) per share. This is a 87.5 percent decrease over losses of $(0.08) per share from the same period last year.